Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CSP Introduces Activ-Blister® Technology for Pharmaceutical Manufacturers

Published: Monday, October 22, 2012
Last Updated: Monday, October 22, 2012
Bookmark and Share
Innovative desiccated blister packaging protects moisture and oxygen-sensitive solid dose pharmaceuticals for better product performance.

CSP Technologies has announced the global launch of its Activ-Blister® desiccated blister packaging for the pharmaceutical industry.

Activ-Blister® desiccant film technology controls the internal atmosphere of each individual blister cavity, protecting moisture and oxygen-sensitive solid dose pharmaceuticals.

The result is optimized product stability, increased shelf-life, and greater consumer convenience.

Activ-Blister® also helps ensure consumer safety, because unlike conventional desiccants, there is no chance of accidental ingestion.

Activ-Blister® offers manufacturers superior flexibility in packaging design, providing an opportunity to differentiate their products.

By eliminating the need for traditional desiccant tablets in separate blister wells, Activ-Blister® allows for a slimmer, more convenient packaging form-factor while simplifying the end-user experience.

In addition, by featuring product protection without increased blister size, Activ-Blister® provides manufacturers with potential cost savings through reduced material usage, freight costs and fuel consumption.

“Activ-Blister® is an entirely new approach to protecting pharmaceuticals with specialized packaging that can build a unique identity for brands,” according to Dan L’Ecuyer, Vice President of Sales & Marketing at CSP Technologies.

L’Ecuyer continued, “Rather than use a desiccant chip inside a separate well in a blister, our proven technologies provides all the protection without increasing blister size and material or shipping costs.”

CSP’s patented technology integrates precise desiccant, gas-absorption, and sealing properties into the blister-pack itself, extending shelf life and product performance.

Activ-Blister® exhibits excellent performance capacity with moisture absorption up to 20mgs and oxygen scavenging up to 30ccs.

In addition, CSP’s Activ-Blister®® technology is available in a variety of sizes, including all type of round tablets and capsules up to size 0, with either multilayer barrier films or aluminum foil blisters to provide protection from both moisture and oxygen.

“Safely preserving drug potency and extending shelf life are high priorities for pharmaceutical manufacturers, and for the patients who rely on their products,” says L’Ecuyer.

“Activ-Blister®, CSP’s breakthrough solid dose packaging technology provides a strong product solution that meets customer needs while also safeguarding patient health.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
New Diabetes Drug has Unexpected Side Effect
A type of drug used to treat diabetes may reduce the risk of developing Parkinson’s disease, according to new research.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Cannabis May Be Used to Treat Fractures
TAU researcher finds non-psychotropic compound in marijuana can help heal bone fissures.
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
Creating More Potent Vaccines
Yale researchers uncovered a new role for a type of immune cell, known as regulatory T cells, in promoting long-term immunity.
Potential Therapeutic for Blinding Eye Disease
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Global Search for Next Antibiotic
University of Queensland researchers have launched a global search to discover antibiotics capable of combating superbug bacteria that are resistant to current antibiotics.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!